Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease – a randomized trial

Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease – a randomized trial

Abstract Background Chronic kidney disease (CKD) is a major risk factor for cardiovascular disease (CVD), partly due to endothelial dysfunction and chronic inflammation. Vitamin D treatment in end stage renal disease is suggested to modulate the immune system and lead to improved outcomes. We and ot...

Full description

Bibliographic Details
Main Authors: Ladan Mansouri, Kristina Lundwall, Ali Moshfegh, Stefan H. Jacobson, Joachim Lundahl, Jonas Spaak
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Nephrology
Subjects:
Chronic kidney disease
Endothelial function
Inflammation
VEGF
Micro RNA
Paricalcitol
Online Access:http://link.springer.com/article/10.1186/s12882-017-0576-8

Internet

http://link.springer.com/article/10.1186/s12882-017-0576-8

Similar Items